Form Type: 4

SEC EDGAR Link
Accession Number:0001708138-20-000082
Date:2020-07-01
Issuer: REGENERON PHARMACEUTICALS, INC. (REGN)
Original Submission Date:

Reporting Person:

BROWN MICHAEL S
777 OLD SAW MILL RIVER ROAD
TARRYTOWN, NY 10591

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2020-07-01 M 3,613 a $413.33 4,256 direct
COMMON STOCK 2020-07-01 S 100 d $601.70 4,156 direct
COMMON STOCK 2020-07-01 S 627 d $603.39 3,529 direct
COMMON STOCK 2020-07-01 S 960 d $604.82 2,569 direct
COMMON STOCK 2020-07-01 S 401 d $605.78 2,168 direct
COMMON STOCK 2020-07-01 S 319 d $608.59 1,849 direct
COMMON STOCK 2020-07-01 S 200 d $609.51 1,649 direct
COMMON STOCK 2020-07-01 S 100 d $615.23 1,549 direct
COMMON STOCK 2020-07-01 S 200 d $616.49 1,349 direct
COMMON STOCK 2020-07-01 S 100 d $623.07 1,249 direct
COMMON STOCK 2020-07-01 S 6 d $624.19 1,243 direct
COMMON STOCK 2020-07-01 S 200 d $607.35 1,043 direct
COMMON STOCK 2020-07-01 S 400 d $612.29 643 direct
COMMON STOCK 2020-07-01 0 $0.00 5,000 indirect f9
COMMON STOCK 2020-07-01 0 $0.00 11,349 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
NON-QUALIFIED STOCK OPTION (RIGHT TO BUY) 413.33 2020-07-01 deemed execution date M 3,613 (d) 2025-01-02 common stock 3,613 $413.33 7,225 direct
Footnotes
IDfootnote
f1 disposition/acquisition made pursuant to a plan intended to comply with rule 10b5-1(c).
f2 represents volume-weighted average price of sales of 627 shares of company stock on july 1, 2020 at prices ranging from $602.95 to $603.85. upon request by the commission staff, the company, or a security holder of the company, the reporting person will provide full information regarding the number of shares sold by the reporting person on july 1, 2020 at each separate price.
f3 represents volume-weighted average price of sales of 960 shares of company stock on july 1, 2020 at prices ranging from $604.16 to $605.03. upon request by the commission staff, the company, or a security holder of the company, the reporting person will provide full information regarding the number of shares sold by the reporting person on july 1, 2020 at each separate price.
f4 represents volume-weighted average price of sales of 401 shares of company stock on july 1, 2020 at prices ranging from $605.25 to $606.19. upon request by the commission staff, the company, or a security holder of the company, the reporting person will provide full information regarding the number of shares sold by the reporting person on july 1, 2020 at each separate price.
f5 represents volume-weighted average price of sales of 319 shares of company stock on july 1, 2020 at prices ranging from $608.14 to $609.12. upon request by the commission staff, the company, or a security holder of the company, the reporting person will provide full information regarding the number of shares sold by the reporting person on july 1, 2020 at each separate price.
f6 represents volume-weighted average price of sales of 200 shares of company stock on july 1, 2020 at prices ranging from $609.22 to $609.80. upon request by the commission staff, the company, or a security holder of the company, the reporting person will provide full information regarding the number of shares sold by the reporting person on july 1, 2020 at each separate price.
f7 represents volume-weighted average price of sales of 200 shares of company stock on july 1, 2020 at prices ranging from $607.10 to $607.59. upon request by the commission staff, the company, or a security holder of the company, the reporting person will provide full information regarding the number of shares sold by the reporting person on july 1, 2020 at each separate price.
f8 represents volume-weighted average price of sales of 400 shares of company stock on july 1, 2020 at prices ranging from $612.21 to $612.35. upon request by the commission staff, the company, or a security holder of the company, the reporting person will provide full information regarding the number of shares sold by the reporting person on july 1, 2020 at each separate price.
f9 these shares are held in a trust for the benefit of the reporting person's immediate family members. the reporting person's spouse is trustee of the trust. the reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of section 16 or for any other purpose.
f10 the stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
WhaleWisdom Logo

Elevate your investments